| abstract |
An antibody drug useful for the treatment of multiple myeloma is provided. Compositions and molecules based on isolated human monoclonal antibodies, and related antibodies, that bind to CD38 antigen that is highly expressed on the surface of human blood cells, particularly malignant plasma cells such as multiple myeloma. Also, pharmaceutical compositions comprising human antibodies, and therapeutic and diagnostic methods for using human antibodies. [Selection figure] None |